| Symbol | Company | Owner | Relationship | Date | Transaction | Cost | # Shares | Value ($) | Total Shares | Filing | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| CLRB | Cellectar Biosciences, Inc. | Swirsky Douglas J | Director | Sep 14, 2021 | Buy | $1.04 | 25,000 | 26,000 | 25,000 | Sep 14, 2021, 04:00 PM | |
| RNN | REXAHN PHARMACEUTICALS, INC. | Swirsky Douglas J | President and CEO | Jan 29, 2019 | Buy | $0.63 | 50,000 | 31,720 | 50,000 | Jan 30, 2019, 07:32 AM | |
| GNVC | GENVEC INC | Swirsky Douglas J | President and CEO | Jun 16, 2017 | Option Exercise | $5.60 | 25,000 | 140,000 | 50,250 | Jun 20, 2017, 04:33 PM | |
| GNVC | GENVEC INC | Swirsky Douglas J | President and CEO | Jun 16, 2016 | Option Exercise | $7.19 | 20,930 | 150,487 | 29,320 | Jun 20, 2017, 04:33 PM | |
| GNVC | GENVEC INC | Swirsky Douglas J | President & CEO | Sep 16, 2016 | Buy | $0.50 | 10,000 | 5,000 | 252,500 | Sep 16, 2016, 03:09 PM | |
| GNVC | GENVEC INC | Swirsky Douglas J | President & CEO | Dec 14, 2015 | Buy | $2.00 | 5,000 | 10,000 | 242,500 | Dec 15, 2015, 09:33 AM | |
| GNVC | GENVEC INC | Swirsky Douglas J | President & CEO | Dec 15, 2014 | Buy | $1.90 | 5,500 | 10,450 | 237,500 | Aug 07, 2015, 02:12 PM | |
| GNVC | GENVEC INC | Swirsky Douglas J | President & CEO | Dec 15, 2014 | Option Exercise | $1.90 | 5,500 | 10,450 | 237,500 | Dec 15, 2014, 04:19 PM | |
| GNVC | GENVEC INC | Swirsky Douglas J | Senior Vice President & CFO | Aug 12, 2011 | Buy | $2.30 | 25,000 | 57,463 | 27,000 | Aug 16, 2011, 10:47 AM |
Menu